Eric Boutin

Eric Boutin is a digital health investor, board member, and serial entrepreneur dedicated to transforming healthcare through science and technology. He helps founders launch, fund, and scale companies through Harvard Street Advising. Previously, he was a Venture Chair at Redesign Health, a digital health venture studio and seed fund, where he created and financed health tech startup companies. Before that, he was a Managing Director at dRx Capital, Novartis’ digital health venture capital fund, where he led early-stage investments in pharma tech, patient care, and healthcare AI. Prior to dRx, Eric was Founder and CEO of Evolve, an AI-powered consumer tech company, which was acquired by HubSpot (NYSE: HUBS). He was Founder and CEO of Good Start Genetics, a reproductive health and genomics company, which was acquired by Invitae (NYSE: NVTA). Eric was also an EIR at Longwood Fund, where he led early-stage biotech deals and founded Flex Pharma, a neuromuscular sports performance company, which went on to IPO (NASDAQ: FLKS). Eric holds an MBA from Harvard Business School and a B.A. in Economics from Duke University.